INTRODUCTION
Noroviruses (NoVs) represent one of the most common causes of enteric disease in humans [1, 2] . The prevalence of NoV in children with acute gastroenteritis ranges from 6% to 48% [1] [2] [3] . NoVs cause significant mortality and morbidity worldwide with 200 000 deaths each year in children aged <5 years, 64 000 paediatric hospital admissions and 900 000 paediatric hospital visits in developed countries each year [4] .
NoVs, family Caliciviridae, are non-enveloped viruses with a single-stranded, positive-sense, polyadenylated RNA genome of about 7500 nucleotides in length [5] , organized into three open reading frames (ORFs), ORF1, 2, and 3, which encode a polyprotein including the RNA-dependent RNA polymerase (RdRp), the major capsid protein, and a small capsid protein, respectively.
NoVs encompass five distinct genogroups (GI-GV) with GI, GII and GIV infecting humans. The NoV genogroups are further divided into genotypes and variants based on sequence diversity [5] . Along with point mutations, recombination events seem to contribute largely to the genetic variability of NoVs [6] . The ORF1/ORF2 junction region is a recombination hotspot and this creates various combinations of RdRp and capsid types [6] . Multi-target characterization of NoVs in the RdRp region (diagnostic regions A and B) [7] [8] [9] [10] and capsid gene (diagnostic regions C-D) [11] [12] [13] [14] is therefore necessary to characterize precisely NoVs.
Thus far, 14 GI and 29 GII RdRp genotypes, and eight GI and 23 GII capsid genotypes have been described. RdRp genotypes are designated by a capital P (for 'polymerase'), followed by an arabic number, i.e. GII.P4, in order to avoid confusion with capsid type nomenclature [15] .
Over the last decade the most common combinations of RpRd/capsid genotypes in the circulating NoV strains were GII.P4_GII.4 and GII.Pb_GII.3 [16] . GII.4 NoVs are highly heterogeneous genetically and evolve quickly, generating new variants every 2 or 3 years [17] [18] [19] [20] . Some GII. [16, 21] .
While reports on NoV infections/outbreaks are numerous, studies describing the molecular epidemiology of NoVs associated with sporadic gastroenteritis are scanty, usually spanning a short time frame [16] . However, gathering information on the epidemiology of NoVs is pivotal for tracking the origin of infections, understanding the dynamics of NoV circulation and devising appropriate public health intervention strategies. Patients hospitalized with gastroenteritis are a good target for gathering epidemiological information on enteric pathogens circulating in the community.
This study describes the results of a 5-year (2007-2011) hospital-based surveillance activity for sporadic NoV infections associated with gastroenteritis in the area of Parma, Northern Italy. Molecular characterization in the ORF1 and ORF2 of a representative selection of NoV strains was achieved in order to generate a reliable picture of NoV molecular epidemiology.
MATERIALS AND METHODS

Stool specimens
Stool samples of 2834 children (age range 0-169 months, median age 33 months) with acute gastroenteritis attending the Maternal Infantile Department of the University Hospital of Parma, Northern Italy, as inpatients (84·7%) and outpatients (15·3%) during January 2007-December 2011 were submitted for virological investigations at the Virological Unit of the Department of Pathology and Laboratory Medicine of the same University Hospital.
The faecal specimens were clarified in 10% (w/w) suspensions in phosphate-buffered saline (PBS, pH 7·2) and analysed by electron microscopy (EM), latex agglutination for group A rotavirus (RV) and adenovirus (AdV) (Orion Diagnostica, Finland), and inoculated onto cell cultures as previously reported [22] . Cytopathogenic agents were identified by EM, neutralization tests using Lim Benyesh-Melnick antisera pools [23, 24] or EM and polyacrylamide gel electrophoresis [25, 26] .
RNA extraction and detection of NoV in clinical samples
For NoV detection, nucleic acids were automatically extracted by the NucliSens easyMAG instrument (bioMérieux, France) from 500 μl of stool suspension in a final volume of 25 μl. Following the manufacturer's instructions, detection of NoV RNA was performed using the RT Kit Plus (Nanogen Advanced Diagnostics, Italy) for reverse transcription (RT), and the NoV Oligomix Alert kit (Nanogen Advanced Diagnostics) for nested PCR (nPCR), targeting a 174-176 bp fragment of NoV RdRp, using CPE-RNA (Nanogen Advanced Diagnostics) as an internal RNA standard control.
Stool samples, faecal suspensions and first-round PCR products were stored at −20°C until use.
Nucleotide sequencing and molecular typing
Sequence analysis was undertaken on amplicons (327 bp in length), yielded with primer pair JV12/ JV13 that target the ORF1 RdRp region A [22] , from a set of NoV-positive specimens, selected according to the seasonal distribution of NoV infections.
For potential recombinant genomes of NoVs, and to exclude cases of mixed infection, the partial ORF1 RdRp and ORF2 capsid gene sequences along with the junction between RdRp and capsid (region A-C, 1110 bp) of a selection of strains representative of the RdRp lineages and sublineages were amplified by RT-PCR using primers JV12 and G2R1 [8, 14] .
The Superscript One-Step RT-PCR for Long Templates kit (Invitrogen, USA) was used. Briefly, 5 μl extracted RNA was added to 12·5 μl of 2 × reaction Novel norovirus GII.4 strainmix, 4·5 μl H 2 O, 0·5 μl RT/Platinum Taq HiFi mix, containing 10 pmol of each primer. The reaction was performed in a PerkinElmer 9700 Thermal Cycler (Applied Biosystems, USA) with the following temperature conditions: 42°C for 60 min, 94°C for 2 min, 40 cycles at 94°C for 1 min, 50°C for 2 min and 68°C for 2 min, followed by 72°C for 10 min. Finally, amplicons of ORF2 region D (254 bp) were also produced from GII.4 strains using published primers and protocols [11] .
The PCR products were electrophoresed on ethidium bromide-stained 2% agarose gel at 120 V for 40 min, visualized under UV light by GelDoc XR instrument (Bio-Rad Laboratories, USA), and purified using QIAquick Gel Extraction kit (Qiagen, Germany). Sequencing was performed using the PCR primers and BigDye Terminator Cycle Sequencing kit (Applied Biosystems) on an automated DNA sequencer (ABI 3730, PerkinElmer-Applied Biosystems, USA). All sequences were typed with the genotyping tool for NoVs (http://www.rivm.nl/ mpf/norovirus/typingtool) [27] .
Phylogenetic analysis of NoV GII.4
In order to investigate the genetic relationship among GII.4 strains, phylogenetic analysis was performed with the generated RdRp and capsid sequences for NoV GII.4 strains identified during the study period. The sequences were analysed using MEGA 5·0 software [28] . Maximum composite likelihood was used as the substitution method, and the neighbour-joining method was used for construction of the phylogenetic tree. The reliability of the phylogenetic tree was assessed by bootstrap re-sampling over 1000 replicates. The BLAST web-based analysis tool with default values was used to find homologous hits in the sequence database (GenBank, NCBI). The nucleotide sequences have been deposited in GenBank under accession numbers KF743088-KF743123 (RdRp region), and KF743064-KF743087 (capsid region).
Statistical analysis
Statistical analysis was performed in order to compare the rates of detection of NoVs in different age groups and seasons, and to understand whether some NoV genotypes may preferentially infect some age groups, or whether patients with co-infections are more susceptible to some NoV strains. The χ 2 test was applied to the data, using GraphPad instat v. 3·05 for Windows (GraphPad Software, USA), with P < 0·05 considered to be significant.
RESULTS
Epidemiological features and NoV genotyping
NoV was detected as a single pathogen in 368 (12·98%, with a range from 9·8% in 2011 to 17·2% in 2008) cases whereas, 50 (1·8%), 13 (0·2%) and four (0·1%) samples had mixed infections with RV, AdV and enterovirus, respectively (Table 1) . A total of 296 (68·04%) of the NoV-positive samples were from children aged <3 years (P = 0·0001) (Fig. 1 ). Of this group of patients, 46 (15·54%) children showed mixed infection with RV in 35 cases (52·23%), AdV in nine cases (13·43%) and enterovirus in two cases (2·98%). The monthly distribution plot showed that NoV was detected throughout the year, except in July 2007 and July-August 2011, with an increasing number of infections during the autumn-winter period (73·56%; 320/435) (P = 0·0001) (Fig. 2) . A total of 217 (49·88%) NoV strains were sequenced in the RdRp (region A). Seven typed NoVs (3·22%) belonged to GI, including four different genotypes (GI.P1, GI.P2, GI.P4, GI.P8), and 210 (96·77%) belonged to GII, of which 168 (80%) were characterized as GII.P4 (Table 2, Fig. 3 was found between genotypes and co-infections. Similarly, different NoV genotypes were found in various age groups. The distribution in age groups of the NoV genotypes matched the distribution of NoV prevalences by age. A statistical correlation was observed between GII.P4 Den Haag 2006b NoV and age <3 years (P = 0·0078).
Phylogenetic analysis of GII.4
Phylogenetic clustering with GII.4 reference strain sequences from Noronet European genotyping tool displayed the genetic relationships among the 168 RdRp GII.4 genotypes detected in this study. In order to eliminate redundancy and prepare a readable figure, 36 sequences representative of the topology of branching of the RdRp GII.4 phylogenetic tree were used to prepare the tree in Figure 4a The capsid phylogenetic tree of 24 NoV Italian GII.4 sequences identified in this study showed that the clustering patterns were consistent with those observed in the RdRp-based analysis with the divergent lineage of the GII.4 New Orleans 2009 strains detected in 2011 (bootstrap value 45%) (Fig. 4b) . This lineage was phylogenetically distinct also from the new GII.4 Sydney 2012 reference strain. In both the capsid regions C and D, the 2011 GII.4 viruses differed by 3-4% from the GII.4 New Orleans 2009 variant.
DISCUSSION
NoV is regarded as a major aetiological agent of sporadic diarrhoea in infants and young children [1] [2] [3] [4] [5] . During 5 years of surveillance for viral agents in sporadic cases of childhood acute gastroenteritis in Parma, Northern Italy, NoV was detected in 15·34% of children. The prevalence rates of NoV infection (with Table 1 50 (1·8%) 13 (0·5%) 6 (0·2%)
(0·1%)
NoV, Norovirus; RV, rotavirus; AdV, adenovirus; EV, enterovirus; ReoV, reovirus; HCaV, calicivirus observed by electron microscopy.
NoV as single pathogen) ranged between 9·8% in 2011 and 17·2% in 2008, revealing annual variations, as observed elsewhere [16] . NoV infection occurred at higher frequency in children aged <3 years (68·04% in this study), an age-related pattern that has been reported in other studies, confirming the relevance of NoV as a cause of severe gastroenteritis requiring hospitalization in young children [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . In temperate climates NoV infections usually show a seasonal pattern with a peak during the cold months [41] [42] [43] . In this study, seasonal peaks of NoV activity were revealed between January and February every year from 2007 to 2010, while in 2011 the activity was prolonged and a peak was reached in April. Moreover, a summer peak was observed in August in 2009. The peaks of NoV activity tended to overlap with or to anticipate the peaks of RV activity in all the surveyed years, except in 2011, when this pattern was inverted (data not shown).
Genotyping of the NoV strains identified during 2007-2011 revealed that different NoV genotypes did co-circulate during the study period and that several reported GII.4 variants were also detected in this cohort. The predominance of GII.4 NoVs (77·4%) is consistent with the literature [8, 16, 17, 20] . NoV GII.4 strains appear to evolve with genetic drift and shift mechanisms, with the periodic onset and rapid global spread of pandemic variants [8, 16, 17, 20] . This temporal pattern of evolution was also documented in our study. Variant GII. . This is not surprising as the onset and spread of novel GII.4 variants is not always related to increase in NoV activity [17] . Whether this novel GII.4 strain may represent a novel GII.4 variant should be assessed in larger and concerted epidemiological studies and with analysis of the data retrospectively. However, hospital-based surveillance studies can offer a reliable approach to monitor promptly the onset on novel NoV strains and variants in a settled population. NoV RdRp genotypes GII.P16, GII.Pb, GII.Pe, and GII.Pg associated with multiple capsid types were identified in this study, suggesting the circulation of several recombinant strains. For these strains, SimPlot analysis on ORF1/ORF2 contigs confirmed the recombinant nature, with the breakpoint being located in the ORF1/ORF2 junction region (data not shown). NoV recombination has been described frequently, and the crossover points are usually located at highly conserved sequence stretches, such as the ORF1/ORF2 junction region [6] . In recent years, the recombinant NoV strains GII.Pb/Hilversum have been found to be common agents of gastroenteritis in Europe, chiefly in children. GII.Pb/Hilversum NoV strains share a common polymerase gene and display a variety of capsid genes, such as GII.1 (Hawaii), GII.2 (Snow Mountain), GII.3 (Toronto) and GII.4 (Lordsdale) [16] . Interestingly, in the present study we observed 2010 NoV strains with either RdRp genotypes GII.Pe or GII.Pg apparently replacing NoV GII.Pb, which was common before 2010, suggesting a temporal shift. Many novel RdRp/capsid genotypes (GII.P7_GII.6, GII.P16_GII.3, GII.P16_GII.13, GII. Pe_GII.2, GII.Pe_GII.4 2007) were identified for the first time in sporadic cases of acute gastroenteritis in Italy, confirming that multi-target (ORF1-and ORF2-based) analysis is required in order to characterize properly NoV strains.
In conclusion, during a 5-year surveillance period, GII.4 were the predominant NoV strains in Northern Italy. Moreover, a candidate novel GII.4 variant was identified and a variety of NoV recombinants were detected for the first time in the country.
Since the epidemiology of NoV changes rapidly, enhanced monitoring of circulating NoVs will allow us to understand the current state of NoV infections in the population and support appropriate future public health intervention strategies against this important cause of sporadic childhood gastroenteritis.
